SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DALPIAZ, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.926
EU - Europa 3.188
AS - Asia 2.593
SA - Sud America 41
AF - Africa 18
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 17.777
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.891
CN - Cina 1.173
UA - Ucraina 930
SG - Singapore 647
IT - Italia 523
TR - Turchia 519
DE - Germania 481
GB - Regno Unito 376
SE - Svezia 259
FI - Finlandia 227
PL - Polonia 176
FR - Francia 72
IN - India 61
ID - Indonesia 51
CA - Canada 34
HK - Hong Kong 29
PK - Pakistan 28
CZ - Repubblica Ceca 25
BR - Brasile 24
BE - Belgio 23
NL - Olanda 18
LT - Lituania 17
IR - Iran 16
AT - Austria 14
JP - Giappone 14
VN - Vietnam 14
EG - Egitto 13
RU - Federazione Russa 13
CO - Colombia 12
TW - Taiwan 11
IE - Irlanda 7
IQ - Iraq 7
KR - Corea 7
RO - Romania 6
TH - Thailandia 5
ZA - Sudafrica 5
AU - Australia 4
CH - Svizzera 4
HU - Ungheria 4
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
PH - Filippine 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
CL - Cile 2
ES - Italia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AR - Argentina 1
BG - Bulgaria 1
KH - Cambogia 1
MN - Mongolia 1
MX - Messico 1
NO - Norvegia 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 17.777
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.460
Fairfield 1.336
Jacksonville 1.010
Houston 998
Chandler 851
Santa Clara 716
Ashburn 628
Ann Arbor 622
Wilmington 556
Seattle 526
Singapore 493
Cambridge 480
Izmir 334
Nanjing 294
Princeton 226
Beijing 195
Ferrara 192
Boardman 188
Warsaw 176
San Diego 116
Addison 103
Nanchang 97
Milan 91
New York 83
Shenyang 78
Hebei 73
Shanghai 70
Tianjin 51
Jakarta 50
Changsha 49
Falls Church 49
Bremen 47
Los Angeles 46
Redwood City 46
San Mateo 46
Helsinki 44
Dearborn 43
Jiaxing 35
London 34
Kunming 33
Norwalk 31
Mountain View 28
Jinan 26
Hong Kong 23
Zhengzhou 22
Brussels 20
Philadelphia 19
Auburn Hills 18
Ningbo 18
Frankfurt am Main 16
Munich 16
Tappahannock 16
Toronto 16
Washington 16
Bologna 15
Düsseldorf 15
Olomouc 15
Verona 15
Indiana 13
Lanzhou 13
Orange 13
Rome 13
Hyderabad 12
Guangzhou 11
Ottawa 11
Vienna 11
Hangzhou 10
Islamabad 10
Karachi 10
Leawood 10
Wuhan 10
Augusta 9
Dong Ket 8
Guarda Veneta 8
Hefei 8
Redmond 8
Tafahnah al Ashrāf 8
Taizhou 8
Dallas 7
Falkenstein 7
Medellín 7
Amsterdam 6
Changchun 6
Des Moines 6
Monmouth Junction 6
Ardabil 5
Bogotá 5
Brno 5
Brooklyn 5
Dublin 5
Gurgaon 5
Ho Chi Minh City 5
Islington 5
Paris 5
Pune 5
Argenta 4
Haikou 4
Itajaí 4
Jaipur 4
Masi Torello 4
Totale 13.229
Salva come PNG Salva come JPEG
Nome #
C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor 253
Nose-to-brain delivery of antiviral drugs: A way to overcome their active efflux? 203
Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently? 189
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 160
Application of the “in-oil nanoprecipitation” method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 154
Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes 154
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives. 153
Physicochemical stability of cabazitaxel and docetaxel solutions 150
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 140
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles 140
Conjugation of aspirin with vitamin C: uptake and stability studies 135
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 133
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 131
Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules 131
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 131
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries 130
Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity. 129
Binding thermodynamics at A1 and A2A adenosine receptors 128
From Physical Mixtures to Co-Crystals: How the Coformers Can Modify Solubility and Biological Activity of Carbamazepine 125
Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: effect of steroids, flavonoids and NSAIDs. 123
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 123
Solid microparticles based on chitosan or methyl-beta-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate 122
Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate 120
Conformational Aspects of Human Formyl-peptide Receptor Agonists 119
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 118
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 116
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate 115
A concerted binding study using binding measurements, X-ray structural data and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines to mitochondrial benzodiazepine receptors 115
Progress in drug delivery to the central nervous system by the prodrug approach 115
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid 114
Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study 113
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres. 112
Polymeric nanoparticles as drug controlled release systems: a new formulation strategy for drugs with small or large molecular weight 112
Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation 112
Conformational aspects of human formylpeptide receptor antagonists 111
Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A 1 receptors of LUF5831, a novel nonadenosine-like agonist 110
Binding thermodynamics of 5-HT(1A) receptor ligands 110
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 108
Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs? 108
Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration 108
Poly(lactic acid) microspheres for the sustained release of antiischemic agents 107
Synthesis and biological evaluation of pro-drugs of GW196771, a potent glycine antagonist acting at the NMDA receptor 107
Exploring the Use of Spray Congealing to Produce Solid Dispersions with Enhanced Indomethacin Bioavailability 107
Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents 107
Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles 106
null 106
Peptide derivatives as agonists or antagonists of formylpeptide receptors: analysis of their effects on neutrophils 105
Dopamine-sensitive adenylyl cyclases in neuronal development: physiopathological and pharmacological implications. 105
Thermodynamics of full agonist, partial agonist and antagonist binding to wild type and mutant adenosine A1 receptors. 105
Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review 105
Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells 104
Solid lipid microparticles for the stability enhancement of a dopamine prodrug 103
null 103
Temperature dependence of the affinity enhancement of selective adenosine A1 receptor agonism: A thermodynamic analysis 102
Binding thermodynamics of adenosine A2a receptor ligands 101
Nuclear Retinoic Acid Receptor Beta as a Tool in Chemoprevention Trials 100
Determination of the adenosine A1 agonist N6-cyclopentyladenosine in rat blood by solid-phase extraction and HPLC 99
Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System? 99
Characterization of A2A Adenosine Receptors in Human Lymphocyte Membranes by [3H]-SCH 58261 Binding 99
Pharmacological and Biochemical Characterization of Purified A2A Adenosine Receptors in Human Platelet Membranes by [3H]-CGS 21680 Binding 98
Biochemical and pharmacological characterization of periodate-oxidized adenosine analogues at adenosine A1 receptors. 98
Thermodynamics of 5-HT3 receptor binding discriminates agonistic from antagonistic behaviour 97
Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy (R)) in allergic rhinitis treatment 97
Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in-vivo preclinical pharmacokinetic study 97
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 96
Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists 95
An RPE cell line as a useful in vitro model for studying retinoic acid receptor beta: expression and affinity. 94
Pharmacological, biochemical and thermodynamic characterization of purified adenosine A2A receptors in human platelet membranes by [3H] CGS 21680 binding 94
Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H] SCH 58261 binding 94
N-ureido peptide derivatives as antagonists towar human neutrophil formylpeptide receptor 94
From crystal to solution and across the membranes: the case of carbamazepine co-crystals 94
Temperature dependence and GABA modulation of b-carboline binding to rat cerebellum benzodiazepine receptors. 93
null 93
Binding thermodynamics of serotonin to rat brain 5HT1A, 5HT2A and 5HT3 receptors 93
Full and partial agonists and thermodynamic binding parameters of adenosine A1 receptor ligands 92
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 92
Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation. 92
Drug release from pharmaceutical co-crystals: Are therapeutic and safety properties of active pharmaceutical substances retained? 92
null 91
1H-pyrazolo[4,3-d]pyrimidine-7(6H)-one and 5H-pyrazolo[4,3-d] 1,2,3-triazin-4(3H)-one derivatives. Synthesis and in vitro biological activity at adenosine A1 and A2a receptors 91
Incorporation of the polar antiischemic drug N6-cyclopentyladenosine in solid lipid microparticles 90
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 90
null 88
Odorants could elicit repair processes in melanized neuronal and skin cells 88
[3H] SCH 58261 labels adenosine A2A receptors in human lymphocyte membranes 88
Nasal administration and brain targeting of an antiischemic agent 87
Adenosine analogs prodrugs: design, synthesis and chemico-physical characterization of N6-cyclopentyladenosine (CPA) derivatives 85
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 85
Controlled release studies of antiischemic agents encapsulated in poly(lactic acid) nanoparticles. 85
Adenosine A1 receptor: Analysis of the potential therapeutic effects obtained by its activation in the central nervous system 85
Neuroactive molecules and their pro-drugs obtained by conjugation with vitamin c: studies of delivery into the brain. 83
null 83
null 83
Can Thermodynamic Measurements of Receptor Binding Yield Information on Drug Affinity and Efficacy? 82
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 81
Binding therodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 81
METODO PER MODULARE L'ASSORBIMENTO FAGOCITARIO DI UN PRINCIPIO ATTIVO O UN SUO PRECURSORE DA PARTE DI MACROFAGI 81
null 81
The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability 80
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 80
Totale 10.906
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.924
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.955
Totale 85.879
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.885 0 0 0 0 0 391 270 374 244 399 129 78
2020/20212.762 221 314 186 253 94 272 80 297 106 445 364 130
2021/20221.971 50 228 148 120 87 85 77 102 76 163 180 655
2022/20231.972 226 94 53 255 379 306 59 155 249 15 115 66
2023/2024989 120 133 57 24 93 111 35 38 15 19 33 311
2024/20251.777 98 89 379 190 610 411 0 0 0 0 0 0
Totale 18.059